A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1 TCRs.

J Immunol

Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada;

Published: January 2018

AI Article Synopsis

  • A significant portion of T cells in humans can recognize lipids presented by CD1 proteins, and recent research focuses on the interaction between mycobacterial lipids and CD1c-restricted T cells, including their role in autoimmunity and cancer.
  • Utilizing an artificial antigen-presenting cell (aAPC) system, researchers isolated and characterized autoreactive CD1c-restricted T cells, confirming their activation through specific recognition of endogenous lipids.
  • The study identified key residues in the T cell receptor (TCR) that are crucial for autoreactivity, shedding light on the molecular characteristics and diversity of these autoreactive T cells.

Article Abstract

In humans, a substantial portion of T cells recognize lipids presented by the monomorphic CD1 proteins. Recent studies have revealed the molecular basis of mycobacterial lipid recognition by CD1c-restricted T cells. Subsets of CD1c-restricted T cells recognize self-lipids in addition to foreign lipids, which may have implications in human diseases involving autoimmunity and malignancy. However, the molecular identity of these self-reactive T cells remains largely elusive. In this study, using a novel CD1c artificial APC (aAPC)-based system, we isolated human CD1c-restricted autoreactive T cells and characterized them at the molecular level. By using the human cell line K562, which is deficient in MHC class I/II and CD1 expression, we generated an aAPC expressing CD1c as the sole Ag-presenting molecule. When stimulated with this CD1c aAPC presenting endogenous lipids, a subpopulation of primary CD4 T cells from multiple donors was consistently activated, as measured by CD154 upregulation and cytokine production in a CD1c-specific manner. These activated CD4 T cells preferentially expressed TRBV4-1 TCRs. Clonotypic analyses of the reconstituted TRBV4-1 TCR genes confirmed CD1c-restricted autoreactivity of this repertoire, and the strength of CD1c reactivity was influenced by the diversity of CDR3β sequences. Finally, alanine scanning of CDR1 and CDR2 sequences of TRBV4-1 revealed two unique residues, Arg and Tyr, as critical in conferring CD1c-restricted autoreactivity, thus elucidating the molecular basis of the observed V gene bias. These data provide new insights into the molecular identity of human autoreactive CD1c-restricted T cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760327PMC
http://dx.doi.org/10.4049/jimmunol.1700677DOI Listing

Publication Analysis

Top Keywords

cd1c-restricted cells
16
cells
9
human autoreactive
8
autoreactive cd1c-restricted
8
cells preferentially
8
trbv4-1 tcrs
8
cells recognize
8
molecular basis
8
molecular identity
8
cd4 cells
8

Similar Publications

Acute leukemia relapsing after chemotherapy plus allogeneic hematopoietic stem cell transplantation can be treated with donor-derived T cells, but this is hampered by the need for donor/recipient MHC-matching and often results in graft-versus-host disease, prompting the search for new donor-unrestricted strategies targeting malignant cells. Leukemia blasts express CD1c antigen-presenting molecules, which are identical in all individuals and expressed only by mature leukocytes, and are recognized by T cell clones specific for the CD1c-restricted leukemia-associated methyl-lysophosphatidic acid (mLPA) lipid antigen. Here, we show that human T cells engineered to express an mLPA-specific TCR, target diverse CD1c-expressing leukemia blasts in vitro and significantly delay the progression of three models of leukemia xenograft in NSG mice, an effect that is boosted by mLPA-cellular immunization.

View Article and Find Full Text PDF

CD36 family members are TCR-independent ligands for CD1 antigen-presenting molecules.

Sci Immunol

June 2021

Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria 3000, Australia.

CD1c presents lipid-based antigens to CD1c-restricted T cells, which are thought to be a major component of the human T cell pool. However, the study of CD1c-restricted T cells is hampered by the presence of an abundantly expressed, non-T cell receptor (TCR) ligand for CD1c on blood cells, confounding analysis of TCR-mediated CD1c tetramer staining. Here, we identified the CD36 family (CD36, SR-B1, and LIMP-2) as ligands for CD1c, CD1b, and CD1d proteins and showed that CD36 is the receptor responsible for non-TCR-mediated CD1c tetramer staining of blood cells.

View Article and Find Full Text PDF

A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1 TCRs.

J Immunol

January 2018

Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada;

Article Synopsis
  • A significant portion of T cells in humans can recognize lipids presented by CD1 proteins, and recent research focuses on the interaction between mycobacterial lipids and CD1c-restricted T cells, including their role in autoimmunity and cancer.
  • Utilizing an artificial antigen-presenting cell (aAPC) system, researchers isolated and characterized autoreactive CD1c-restricted T cells, confirming their activation through specific recognition of endogenous lipids.
  • The study identified key residues in the T cell receptor (TCR) that are crucial for autoreactivity, shedding light on the molecular characteristics and diversity of these autoreactive T cells.
View Article and Find Full Text PDF

The evolutionarily conserved CD1 family of antigen-presenting molecules presents lipid antigens rather than peptide antigens to T cells. CD1 molecules, unlike classical MHC molecules, display limited polymorphism, making CD1-restricted lipid antigens attractive vaccine targets that could be recognized in a genetically diverse human population. Group 1 CD1 (CD1a, CD1b, and CD1c)-restricted T cells have been implicated to play critical roles in a variety of autoimmune and infectious diseases.

View Article and Find Full Text PDF

A subset of CD1c-restricted T lymphocytes exhibits strong reactivity against leukemia cells. These T cells recognize methyl-lysophosphatidic acid (mLPA), a novel lipid antigen produced by acute leukemia cells. Considering that CD1c-restricted T cells display efficacious anti-leukemia activities in a mouse model, this lipid antigen thus represents a novel target in the immunotherapy of hematological malignancies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!